TrialEpilepsia open2022

Efficacy and tolerability of brivaracetam monotherapy in childhood and juvenile absence epilepsy: An innovative adaptive trial design.

Thomas Bast et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.